MEDPACTO, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,140 KRW | -2.16% |
|
-1.57% | +12.43% |
| 2023 | MedPacto, Inc. announced that it has received KRW 10.85806127 billion in funding from Theragen Etex Co.,Ltd. | CI |
| 2023 | South Korean Shares Nearly Unchanged Ahead of US Inflation Data | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDPACTO, INC. | Bio Therapeutic Drugs | -2.16% | -1.57% | +12.43% | -44.17% | - | 197M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- A235980 Stock
- Charts MedPacto, Inc.
- Comparison Chart
